Physician-Supervised GLP-1 Weight Loss in Palm Beach Gardens

Physician-Supervised Medical Weight Loss Near Palm Beach Gardens, FL

A plan built around your health—not another generic diet

Losing weight can be difficult even when you are making a serious effort. Appetite, sleep, medications, medical conditions, stress, activity, genetics and hormonal changes can all influence weight. That is why NovaGenix begins with a medical conversation rather than a one-size-fits-all program.
NovaGenix Health & Wellness provides physician-supervised medical weight management for adults in Palm Beach Gardens and nearby communities. Our office is located just north of Palm Beach Gardens in Jupiter, Florida.
Care is overseen by Dr. Timothy W. Mackey, D.O., a Florida-licensed osteopathic physician with internal-medicine training and more than two decades of clinical experience.
Your evaluation may include a review of your medical history, current medications, previous weight-loss attempts, health goals and relevant laboratory results. If treatment is appropriate, your individualized plan may include nutrition and activity guidance, prescription weight-management medication and ongoing monitoring.

Why consider medical weight management?

Weight management is not simply a test of willpower. Many factors can affect weight, including eating patterns, physical activity, sleep, medications, health conditions, family history and genetics. A medical evaluation can help identify issues that deserve attention and determine whether prescription treatment is appropriate.NovaGenix focuses on three goals: Understand the full picture. We review your health history, current medications, previous approaches and relevant laboratory information. Choose an appropriate strategy. Recommendations are based on your individual risks, goals and treatment preferences—not a standard package assigned to everyone. Monitor progress responsibly. Follow-up allows the plan to be adjusted for effectiveness, tolerability and changes in your health. Learn more about NovaGenix medical weight-management programs.

What your NovaGenix program may include

A complete medical and medication review

We discuss your weight history, eating patterns, activity, sleep, current health conditions, prescriptions, supplements and previous weight-loss treatments. Some medications and medical conditions can affect appetite, fluid balance or weight, so this review is an important first step.

Laboratory evaluation when indicated

Laboratory testing is selected according to your clinical history and may include markers related to blood sugar, cholesterol, thyroid function, liver and kidney health or other concerns. Not every patient needs the same tests.  

Personalized nutrition and activity guidance

Medication is not a substitute for nutrition, movement, sleep or long-term behavior change. Your plan may include practical protein, fiber, hydration, calorie and activity targets that fit your health needs and daily routine. Resistance exercise may also be recommended to help preserve strength and lean mass during weight loss.

Prescription medication when medically appropriate

Some adults may benefit from an FDA-approved prescription medication for chronic weight management. The right option depends on your medical history, other medications, treatment goals, potential side effects, cost and availability.

Ongoing follow-up and adjustment

Follow-up visits help assess progress, side effects, nutrition, hydration and whether the current plan remains appropriate. Doses and recommendations may be adjusted according to your response; faster is not always better.

GLP-1 weight-loss options: semaglutide and tirzepatide

GLP-1–based medications can help regulate appetite and food intake. Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both GIP and GLP-1 receptors. FDA-approved products containing these active ingredients are used for chronic weight management in eligible patients together with reduced-calorie nutrition and increased physical activity. These medications are not right for everyone, and the specific medication or product should never be selected from an advertisement alone. Dr. Mackey considers your medical history, current medications, laboratory information, treatment goals and risk factors before making a recommendation.

What clinical studies have found

In a 68-week clinical trial involving adults with overweight or obesity and without diabetes, participants receiving once-weekly semaglutide 2.4 mg plus lifestyle intervention lost an average of 14.9% of their starting body weight, compared with 2.4% among participants receiving placebo plus lifestyle intervention. In a separate 72-week trial involving adults with obesity or overweight and without diabetes, average weight reduction with tirzepatide ranged from 15.0% to 20.9% across the studied maintenance doses, compared with 3.1% with placebo. These are study averages, not promises. The trials differed and should not be treated as a direct comparison. Individual results vary according to the medication and dose used, treatment duration, adherence, side effects, health conditions and lifestyle factors.

Who may qualify for prescription weight-loss medication?

For many FDA-approved chronic weight-management medications, adult eligibility generally includes either: a body mass index (BMI) of 30 or higher; or a BMI of 27 or higher together with at least one weight-related health condition, such as high blood pressure, abnormal cholesterol, type 2 diabetes, cardiovascular disease or obstructive sleep apnea. BMI is a screening measure, not a complete diagnosis. Your clinician also considers your health history, body composition, previous treatments, current medications, risks and goals. Meeting a BMI threshold does not automatically mean medication is appropriate.
‍
Find Out Whether Medical Weight Management May Be Right for You

GLP-1 safety and side effects

Common side effects of GLP-1–based medications include nausea, diarrhea, vomiting, constipation and abdominal discomfort. Starting with a lower dose and increasing gradually may improve tolerability, but side effects can still occur. Semaglutide and tirzepatide products also carry important warnings and contraindications. They should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Pregnancy, a history of serious allergic reaction to the medication and certain gastrointestinal, pancreatic, gallbladder, kidney or eye conditions may affect whether a medication is appropriate or how closely a patient should be monitored.This is not a complete list of risks. Dr. Mackey will review the relevant prescribing information, your medical history and alternatives with you before treatment.

Brand-name and compounded medication options

NovaGenix offers both FDA-approved brand-name GLP-1 medications and compounded medication options when they are legally available, medically appropriate and individually prescribed. Compounded medications are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality. If medication is recommended, NovaGenix will explain the specific product being considered, its expected cost, potential benefits and risks, and reasonable alternatives before you decide whether to proceed.

What to expect: your first four steps

1. Schedule your free initial consultation
Call or text 561-277-8260, email info@novagenix.org, or use the consultation form on this page. The initial consultation is free and helps you and NovaGenix determine whether the practice is a good fit for your needs.

2. Meet with the NovaGenix team
Discuss your health history, current medications, previous weight-loss attempts, concerns and goals. Bring recent laboratory results or relevant medical records if you have them. With telemedicine options available, we make the process convenient for patients who have busy schedules, yet want professional medical care.

3. Complete the appropriate evaluation
Dr. Mackey reviews the available information and determines whether additional laboratory testing is needed and whether medication is medically appropriate.

4. Begin and monitor your individualized plan
If you choose to proceed, you receive clear instructions and a follow-up plan. Progress is assessed over time so recommendations can be adjusted for safety, tolerability and effectiveness.

Why Palm Beach Gardens patients choose NovaGenix

Medical weight-loss care serving Palm Beach Gardens from Jupiter

NovaGenix is located at:609 N. Hepburn Avenue, Suite 106 Jupiter, Florida 33458
‍The office is north of Palm Beach Gardens and can be reached from Alternate A1A or I-95 via Indiantown Road.
‍Hours: Monday–Friday, 9:00 a.m.–5:00 p.m.
Phone or text: 561-277-8260

Get Directions to NovaGenix

Frequently asked questions

Take the next step with a physician-supervised plan

If repeated diets have left you frustrated—or you want to know whether a prescription weight-management option is appropriate—start with a medical conversation. NovaGenix will review your goals, explain reasonable options and tell you directly if treatment is not right for you.
‍
NovaGenix Health & Wellness
609 N. Hepburn Avenue, Suite 106 Jupiter, Florida 33458

‍Medical disclaimer: This page is for general educational purposes and does not provide medical advice. Individual results vary. A consultation does not guarantee that medication will be prescribed, and no treatment is appropriate for every patient.

Medical References for the Published Page

National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight & Obesity.
U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information, revised February 2026.
U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information, 2026.
Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384:989–1002.
Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387:205–216.
U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.